LIC MF Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.59% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
1 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹104 Cr
- Created on4 Feb 2019
Fund Ranking
#5
/ 16 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month25.7%
- 1 Year16.5%
- 3 Year (CAGR)22.1%
- All Time (CAGR)17.7%
Category Return
- 6 Month22.8%
- 1 Year17.5%
- 3 Year (CAGR)21.9%
- All Time (CAGR)17.1%
Asset Allocation
- Equity98.5%
- Other1.5%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise6.77%
- Aurobindo Pharma5.30%
- Ipca Laboratories3.05%
- Neuland Laboratories5.74%
- Sun Pharmaceutical Industries10.55%
Fund Information
- Expense Ratio2.67%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Managed By
Sudhanshu Asthana
April 2026 - Present
Dhaval Sangoi
Sep 2026 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 1.01 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 15.86 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 0.37 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.93